| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63a7cd4de3019efd81cca277476f8350 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0229
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-16877 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0208 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-168 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00 |
| filingDate |
2001-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8bda05fea9046cb3a3c11c9d86458d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89b004e9303e06fde35af9d806451dd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc08d5048398fc09afd7532845637a5a |
| publicationDate |
2002-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2431688-A1 |
| titleOfInvention |
Implantable refillable and rate controlled drug delivery device |
| abstract |
Implantable, refillable, rate controlled drug delivery is disclosed that includes a base structure (120) having at least a first opening and a second opening, the base structure defining a chamber (160), a septum (110) covering the first opening and configured to substantially prevent leakage from the first opening to an exterior of the device, a drug delivery tube (130) comprising a first and second distal end, wherein the first distal end of the tube communicates with the chamber through the second opening, and at least one rate-limiting permeable membrane (150) disposed across a passage between the base structure and the second distal end of delivery tube, which membrane passively regulates drug delivery. The drug delivery device is used to provide controlled drug delivery to an internal portion of the body and is advantageously leak-proof and does not rely on a pressure differential to drive the drug from the device. |
| priorityDate |
2000-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |